Advaxis (ADXS) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ayala Pharmaceuticals, Inc. has agreed to sell most of its assets to Immunome, Inc., and as part of the deal, the company has clarified the terms of the $800,000 transaction bonus for their Chief Medical Officer, Dr. Andres Gutierrez. The bonus will waive certain payments or benefits if Dr. Gutierrez’s employment ends after the sale. However, if his employment ceases before the sale’s completion, the original terms of his 2018 employment agreement will remain in effect.
For further insights into ADXS stock, check out TipRanks’ Stock Analysis page.